Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation

被引：2
|
作者：
Nedeltchev, Krassen [1 ,2 ]
机构：
[1] Triemli Hosp, Dept Neurol, CH-8063 Zurich, Switzerland
[2] Univ Bern, Bern, Switzerland
来源：
STROKE | 2012年 / 43卷 / 03期
关键词：
anticoagulation; apixaban; atrial fibrillation; DABIGATRAN;
D O I：
10.1161/STROKEAHA.111.640961
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [41] Stroke and Bleeding in Patients with Atrial Fibrillation and End-Stage Renal Disease Treated with Apixaban Versus Warfarin
    Lara, Joao Manoel Da Silveira
    Dourado, Claudia
    BLOOD, 2023, 142
  • [42] Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration?
    Lip, Gregory Y. H.
    Khan, Ahsan A.
    Olshansky, Brian
    CIRCULATION, 2019, 139 (20) : 2301 - 2303
  • [43] Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs
    Deitelzweig, Steve
    Sah, Janvi
    Kang, Amiee
    Russ, Cristina
    Preib, Madison
    Dhamane, Amol D.
    Ratiu, Anna
    Cato, Matthew
    Alfred, Tamuno
    Levi, Edi
    Di Fusco, Manuela
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 163 : 43 - 49
  • [44] THE SAFETY AND EFFICACY OF APIXABAN VERSUS WARFARIN IN CHRONIC KIDNEY DISEASE PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS
    Chopra, Rebaika
    Kohli, Varun
    Jim, Belinda
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 664 - 665
  • [45] Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study
    Hansson, Astrid Fritz
    Modica, Angelo
    Renlund, Henrik
    Christersson, Christina
    Held, Claes
    Batra, Gorav
    OPEN HEART, 2024, 11 (01):
  • [46] Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
    Alexander, Karen P.
    Brouwer, Marc A.
    Mulder, Hillary
    Vinereanu, Dragos
    Lopes, Renato D.
    Proietti, Marco
    Al-Khatib, Sana M.
    Hijazi, Ziad
    Halvorsen, Sigrun
    Hylek, Elaine M.
    Verheugt, Freek W. A.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2019, 208 : 123 - 131
  • [47] The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group
    Cowper, Patricia A.
    Sheng, Shubin
    Anstrom, Kevin J.
    Stafford, Judith A.
    Lopes, Renato D.
    Davidson-Ray, Linda
    Wallentin, Lars
    Phatak, Hemant M.
    Ansell, Jack
    Dorian, Paul
    Husted, Steen
    McMurray, John J.
    Steg, P. Gabriel
    Alexander, John H.
    Granger, Christopher B.
    Mark, Daniel B.
    CIRCULATION, 2014, 130
  • [48] Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
    Fu, Chung-Ming
    Li, Lung-Chih
    Lee, Yueh-Ting
    Wang, Shih-Wei
    Hsu, Chien-Ning
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [49] Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study
    Wetmore, James B.
    Weinhandl, Eric D.
    Yan, Heng
    Reyes, Jorge L.
    Herzog, Charles A.
    Roetker, Nicholas S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (05) : 569 - +
  • [50] EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS
    Deitelzweig, Steven Bruce
    Sah, Janvi
    Kang, Amiee
    Russ, Cristina
    Preib, Madison
    Dhamane, Amol
    Ratiu, Anna
    Cato, Matthew
    Alfred, Tamuno
    Levi, Edi
    Di Fusco, Manuela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1593 - 1593
12345